Swine CTLA-4 Recombinant Protein

Catalog Number:
RP1534S
Availability:
In stock
Application:
Cell Culture, ELISA Standard, ELISpot Control, Western Blot Control
100% Homology:
Sus scrofa (pig)
  • Swine CTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4, CD152) (catalog RP1534S) is a yeast-derived immune checkpoint protein supplied lyophilized without carrier protein in 10% trehalose; it has no affinity tags and is naturally endotoxin-free, and should be reconstituted in sterile PBS that contains at least 0.1% carrier protein. The protein is ~13.3 kDa, 124 amino acids long (full sequence provided), and >98% pure by SDS-PAGE, with 100% amino-acid homology to pig. Store at -20°C (stable up to twelve months from date of receipt; working aliquots with carrier protein stable ~3 months) and avoid repeated freeze/thaw cycles. Product origin is the USA. It is commonly used to study CTLA-4 signaling and immune regulation (including inhibition of T-cell activation and modulation of immune checkpoint pathways); typical experimental uses include cell-culture stimulation and binding assays, immune checkpoint and signaling studies, ELISA and neutralization assays, flow-cytometry and Western blot controls, and antibody generation/validation. Kingfisher Biotech products are supplied for research applications and are not intended for medicinal, diagnostic, or therapeutic use.
Amino Acid SequenceMHVAQPAVVL ANSRGVASFV CEYGSAGKAA EVRVTVLRRA GSQMTEVCAA TYTVEDELTF LDDSTCTGTS TENKVNLTIQ GLRAVDTGLY ICKVELLYPP PYYVGMGNGT QIYVIDPEPC PDSD (124)
EndotoxinNaturally endotoxin-free
Storage Conditions-20°C
Molecular Weight13.3 kDa
Purity>98% as visualized by SDS-PAGE analysis.
Country Of OriginUSA
  • Swine CTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4, also known as CD152) is an immune checkpoint receptor belonging to the immunoglobulin superfamily that functions as a key negative regulator of T-cell activation in pigs (Sus scrofa). CTLA-4 is primarily expressed on activated CD4⁺ and CD8⁺ T lymphocytes and on regulatory T cells (Tregs) following antigen stimulation. It binds to the costimulatory ligands CD80 (B7-1) and CD86 (B7-2) on antigen-presenting cells such as dendritic cells, macrophages, and B cells, competing with the activating receptor CD28 for these ligands. Engagement of CTLA-4 transmits inhibitory signals that suppress T-cell proliferation, cytokine production, and immune activation, thereby helping maintain immune homeostasis and peripheral tolerance. In swine, CTLA-4 signaling is particularly relevant during viral infections such as porcine reproductive and respiratory syndrome virus (PRRSV), where excessive or dysregulated T-cell responses can influence disease outcome. Pigs are also used as large-animal models for transplantation immunology, and CTLA-4-Ig fusion proteins (similar to the human therapeutic abatacept/belatacept) have been tested in pig-to-nonhuman primate xenotransplantation studies, where blockade of CD28-mediated costimulation through the CTLA-4 pathway helps reduce T-cell-mediated graft rejection. These studies make swine CTLA-4 an important component of translational research on immune checkpoint regulation and tolerance induction in transplantation and immunotherapy.

Please choose a size to see price


Reagents for Animal Model and Animal Health Research

Kingfisher Biotech, Inc.
1000 Westgate Drive
Suite 123
Saint Paul, MN 55114

Phone: 651-646-0089
Fax: 651-646-0095

Animal Antibodies

Newsletter

"